Drug Shortage Report for ROVAMYCINE 500 CAPSULE 1500000 UNIT
Report ID | 19338 |
Drug Identification Number | 01927817 |
Brand name | ROVAMYCINE 500 CAPSULE 1500000 UNIT |
Common or Proper name | Spiramycin capsules |
Company Name | ODAN LABORATORIES LTD |
Market Status | DORMANT |
Active Ingredient(s) | SPIRAMYCIN |
Strength(s) | 1500000UNIT |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 50 |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2017-08-14 |
Actual start date | 2017-08-14 |
Estimated end date | Unknown |
Actual end date | 2018-05-22 |
Shortage status | Resolved |
Updated date | 2018-05-23 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2018-05-23 | English | Compare |
v5 | 2018-05-22 | French | Compare |
v4 | 2018-05-22 | English | Compare |
v3 | 2017-08-15 | English | Compare |
v2 | 2017-08-14 | French | Compare |
v1 | 2017-08-14 | English | Compare |
Showing 1 to 6 of 6